European Association for the Study of Diabetes Annual Meeting

Healio brings you the highlights from the European Association for the Study of Diabetes Annual Meeting. Refer back to this page often for the latest news from EASD, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Top stories from EASD 2018

October 19, 2018
The 54th annual meeting of the European Association for the Study of Diabetes was held earlier this month, and Endocrine Today covered the latest…
Meeting NewsPerspective

CARMELINA: Linagliptin safe, effective in type 2 diabetes with CVD, kidney disease

October 8, 2018
Among adults with type 2 diabetes, established cardiovascular disease and/or chronic kidney disease, the DPP-IV inhibitor linagliptin demonstrated CV…
Meeting NewsPerspective

Leading diabetes groups stress patient-centered care, new therapies in updated consensus report

October 5, 2018
Providers should prioritize patient-centered care for type 2 diabetes that incorporates therapy regimens tailored to specific patient goals, whereas…
Meeting NewsPerspective

Lorcaserin reduces diabetes progression in high-risk adults with obesity, CVD

October 5, 2018
Adults with obesity, prediabetes and established cardiovascular disease randomly assigned to the serotonin receptor agonist lorcaserin were less…
Meeting News

Artificial pancreas improves time-in-range glucose values vs. pump therapy

October 3, 2018
A cohort of patients with type 1 diabetes, including children as young as age 6 years, treated with insulin pump therapy experienced a 10%…
Meeting News

ELIXA: Lixisenatide slows, reduces macroalbuminuria risk in type 2 diabetes with CVD

October 3, 2018
Adults with type 2 diabetes, established cardiovascular disease and macroalbuminuria assigned to the GLP-1 receptor agonist lixisenatide experienced…
Meeting NewsPerspective

HARMONY: Albiglutide reduces CV risk in adults with type 2 diabetes, CVD

October 3, 2018
Adults with type 2 diabetes and atherosclerotic disease randomly assigned to the once-weekly GLP-1 receptor agonist albiglutide experienced a 22%…
Meeting NewsPerspective

Dementia increases risk for death from hypoglycemia in older adults with diabetes

October 2, 2018
Older adults with diabetes and dementia were 67% more likely to die vs. those with diabetes but without dementia, according to findings presented at…
Meeting News

Experimental oral diabetes drug appears safe, effective in Japanese adults

September 23, 2017
Imeglimin, part of a new class of oral agents for type 2 diabetes that target mitochondrial bioenergetics, was found to be safe and effective in…
Meeting News

Biomarker may predict preeclampsia risk in women with type 1 diabetes

September 20, 2017
Pregnancy outcomes in women with childhood-onset type 1 diabetes are commonly poor, and a new biomarker could help predict which women may develop…

Meeting Calendar

European Association for the Study of Diabetes Annual Meeting

September 16, 2019 - September 20, 2019